Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator

Stroke

Volumn 31, Issue 4, 2000, Pages 940-945

  Cipolla, Marilyn J ^a,c   Lessov, Nikola ^b   Clark, Wayne M ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Given Building ^*  (United States)

Author keywords

Arterial wall; Ischemia; Middle cerebral artery; Tissue plasminogen activator

Indexed keywords

ACETYLCHOLINE; ALTEPLASE; SEROTONIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOGRAPHY; ARTERY TONE; ARTERY WALL; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRESSURE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0034117546     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.4.940     Document Type: Article

References (39)

1. Koudstaal PJ, Stibbe J, Vermeulen M. Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator. Br Med J. 1988; 297:1571-1574.
2. The National Institute of Neurological Disorders, and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
3. del Zoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in acute stroke: possibilities and hazards. Stroke. 1986;17:595-607.
4. del Zoppo GJ. Thrombolytic therapy in cerebrovascular disease. Stroke. 1988;19:1174-1179.
5. Brott T. Thrombolytic therapy for stroke. Cerebrovasc Brain Metab Rev. 1991;3:91-113.
6. Pessin MS, del Zoppo GJ, Estol CJ. Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol. 1990;13:271-289.
7. Francis CW. The fibrinolytic system: normal physiology and pathophysiology. In: Comerota AJ, ed. Thrombolytic Therapy for Peripheral Vascular Disease. Philadelphia, Pa: J.B. Lippincott Co; 1995:25-40.
8. del Zoppo GJ. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc Brain Metab Rev. 1994;6:47-96.
9. Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab. 1996;16:1373-1378.
10. Heistad DD, Kontos HA. In: Berne RM, Sperelakis N, eds. Handbook of Physiology: The Cardiovascular System, III. Bethesda, Md: American Physiological Society; 1979:137-182.
11. Johansson B. Myogenic tone and reactivity: definitions based on muscle physiology. J Hypertens. 1989;7(suppl 4):S5-S8.
12. Mellander S. Functional aspects of myogenic vascular control. J Hypertens. 1989;7(suppl 4):S21-S30.
13. Lassen NA, Agnoli A. Upper limit of autoregulation of cerebral blood flow: on the pathogenesis of hypertensive encephalopathy. Scan J Clin Lab Invest. 1972;30:113-115.
14. Johansson B, Li C-L, Olsson Y, Klatzo I.Effect of acute arterial hypertension on the blood-brain barrier to protein tracers. Acta Neuropathol. 1970;1970:16:117-124.
15. Ameriso SF, Sahai S. Mechanisms of ischemia in in situ vascular occlusive disease. In: Welch KMA, Kaplan LR, Reis DJ, Siesjö BK, Weir B, eds. Primer on Cerebrovascular Diseases. New York. NY: Academic Press; 1997:279-285.
16. Mohr JP, Lazar RM, Marshall RS, Gauthier JC, Hier DB. Middle cerebral artery disease. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke, Pathophysiology: Diagnosis and Management. New York, NY: Churchill Livingstone; 1998:427.
17. Cipolla MJ, McCall AL, Lessov N, Porter JP. Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats. Stroke. 1997;28:176-180.
18. Zea Longa E, Weinstein PR, Carlson S, Cummins R, Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91.
19. Clark WM, Lessov N, Lauten JD, Hazel K. Doxycycline treatment reduces ischemic brain damage in transient middle cerebral artery occlusion in the rat. J Mol Neurosci. 1997;9:1-6.
20. Wiederhielm CA. Continuous recording of arteriolar dimensions with a television microscope. J Appl Physiol. 1963;18:1041-1042.
21. Ito U, Ohno K, Nakamura F, Suganuma F, Inaba Y. Brain edema during ischemia and after restoration of blood flow: measurement of water, sodium, potassium content and plasma protein permeability. Stroke. 1979;10:542-547.
22. Kuroiwa T, Shibutani M, Okeda R. Nonhyperemic blood flow restoration and brain edema in experimental focal cerebral ischemia. J Neurosurg. 1989;70:73-80.
23. Tsuchidate R, He Q-P, Smith M-L, Siesjo BK. Regional cerebral blood flow during and after 2 hours of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1997;17:1066-1073.
24. Cipolla MJ, Osol G. Vascular smooth muscle actin cytoskeleton in cerebral artery forced dilatation. Stroke. 1998;29:1-6.
25. Cipolla M, Osol G. Actin polymerization is induced by pressure in vascular smooth muscle and causes contraction of cerebral arteries. Circulation. 1997;96:I-50. Abstract.
26. Hein S, Scheffold T, Schaper J. Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium. J Thorac Cardiovasc Surg. 1995;110:89-98.
27. Doukas J, Cutler AH, Boswell CA, Joris I, Majno G. Reversible endothelial cell relaxation induced by oxygen and glucose deprivation. Am J Pathol. 1994;145:211-219.
28. Plateel M, Dehouck M-P, Torpier G, Cecchelli R, Teissier E. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood brain barrier endothelial cell monolayer. J Neurochem. 1995,65: 2138-2145.
29. Golenhofen N, Doctor RB, Bacallao R, Mandel L. Actin and villin compartmentation during ATP depletion and recovery in renal cultures cells. Kidney Int. 1995;48:1837-1845.
30. Kellerman PS, Norenberg SL, Jones GM. Early recovery of the actin cytoskeleton during renal ischemic injury in vivo. Am J Kidney Dis. 1996;27:709-714.
31. 4 mRNA following focal brain ischemia. Neuroreport. 1996;7: 1613-1616.
32. Cipolla M, Porter JM. The effect of tissue plasminogen activator on cerebral artery vasoreactivity. Stroke. 1998;29:1223. Abstract.
33. Dudani AK, Ganz PR. Endothelial cell surface actin serves as a binding site for plaminogen, tissue plasminogen activator and lipoprotein(a). Br J Haematol. 1996;95:168-178.
34. Rosenberg GA, Navratil M, Barone F, Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab. 1996;16:360-366.
35. Wang X, Feuerstein GZ. Induced expression of adhesion molecules following focal brain ischemia. J Neurotrauma. 1995;12:825-832.
36. Winn RK, Sharar SR, Vedder NB, Harlan JM. Leukocyte and endothelial cell adhesion molecules in ischemia/reperfusion injuries. Ciba Found Symp. 1995;189:63-71.
37. 3 is expressed in selected microvessels after focal cerebral ischemia. Am J Pathol. 1996;149:37-44.
38. Ding L, Coombs GS, Strandberg L, Navre M, Corey DR, Madison E. Origins of the specificity of tissue-type plasminogen activator. Proc Natl Acad Sci U S A. 1995;92:7627-7631.
39. Ellis V, Whawell SA. Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: evidence for a specific tissue plasminogen activator receptor on these cells. Blood. 1997;90:2312-2322.